Efficacy, safety, and health-related quality of life in transplant-ineligible newly diagnosed multiple myeloma patients receiving bortezomib maintenance therapy: a study of the Korean Multiple Myeloma Working Party (KMMWP-174 study)
Jung Yeon Lee, Seung Pil Jung, Suein Choi, Sung-Soo Park, Jin Seok Kim, Je-Jung Lee, Seong Kyu Park, Hyo Jung Kim, Gyeong‐Won Lee, Young Hoon Park, Hyeon-Seok Eom, Jeong‐Ah Kim, Min Kyoung Kim, Yundeok Kim, Ho‐Jin Shin, Ho Sup Lee, Jihyun Kwon, Chang‐Ki Min
IF 7.9Haematologica
초록
제공된 초록이 없습니다.
*본 초록은 AI를 통해 원문을 번역한 내용입니다. 정확한 내용은 하기 원문에서 확인해주세요.
키워드
Multiple myelomaBortezomibMedicineOncologyLenalidomideQuality of life (healthcare)Maintenance therapyInternal medicineChemotherapyNursing